|Articles|March 1, 2013
- BioPharm International-03-01-2013
- Volume 26
- Issue 3
BioPharm International, March 2013 Issue (PDF)
Click the title above to open the BioPharm International March 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 13 years ago
Advancing Analytical Testing and Instrumentation for Biopharmaceuticalsalmost 13 years ago
Lyophilization: A Primeralmost 13 years ago
Vaccine Innovation Yields New Products and Processesalmost 13 years ago
Aggregation of Monoclonal Antibody Products: Formation and Removalalmost 13 years ago
Outsourcing Nontraditional Protein Expression Systemsalmost 13 years ago
The Lifecycle Change of Process Validation and Analytical Testingalmost 13 years ago
Standards-Setting Activities on Impuritiesalmost 13 years ago
Report from Brazilalmost 13 years ago
Catching UpNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
